Rowland Charles A Jr
SEC insider (Form 3/4/5 filer). CIK 0001383292. Director at Generation Bio Co. (GBIO) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in CAMBRIDGE, MA.
Companies Rowland Charles A Jr has filed insider reports for
- Generation Bio Co. (GBIO): Director
- Viking Therapeutics, Inc. (VKTX): Director
Rowland Charles A Jr
CIK: 0001383292
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
4.2K shares- - Feb 9, 2026GBIO
Generation Bio Co.
Tender OfferDirect53.5K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
6K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
2.5K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
1.9K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
1.5K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
5.2K shares- - Feb 9, 2026GBIO
Generation Bio Co.
DispositionDirectStock Option (right to buy)
3K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect3.2K shares- - Oct 27, 2025VKTX
Viking Therapeutics, Inc.
ExerciseDirectStock Option (Right to Buy)
22K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 9, 2026 |  GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 4,246 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Tender Offer | 53,475 | - | $0 | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 6,000 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 2,500 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 1,920 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 1,500 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 5,200 | - | - | Direct |
| Feb 9, 2026 | GBIO Generation Bio Co. | Disposition Stock Option (right to buy) | 3,000 | - | - | Direct |
| Jan 2, 2026 |  VKTX Viking Therapeutics, Inc. | Award | 3,150 | - | $0 | Direct |
| Oct 27, 2025 | VKTX Viking Therapeutics, Inc. | Exercise Stock Option (Right to Buy) | 22,000 | - | - | Direct |
1-10 of 18 transactions